Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: IMR Evaluation in Patients with Coronary Sinus Reducer Implantation (INROAD Study) [NA]
This clinical trial update reports the completion of the INROAD study evaluating IMR in patients with Coronary Sinus Reducer implantation fo…
-
CLINICAL_TRIALS research · 2025-01-30Clinical Trial Update: Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) Trial [NA]
The CorCMR trial evaluating coronary microvascular angina using cardiac magnetic resonance imaging is currently active but not recruiting. T…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
The REVEALPLAQUE trial, a prospective multicenter study using coronary CT angiography to analyze plaque, has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris [Phase 2]
Phase 2 trial of adenovirus VEGF-D gene therapy (AdvVEGF-D) for refractory angina pectoris has completed.
-
FDA approval · 2025-01-08FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s supplemental application for Isosorbide Dinitrate, indicating an approved modification to the generic product …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-03FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for amlodipine besylate from Ascend Laboratories, LLC. Amlodipine besylate is a generic calcium chan…
-
FDA approval · 2024-12-23FDA Approved: FELODIPINE — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Felodipine from Carlsbad Technology, Inc., indicating an update to the drug's regulatory status …
-
FDA approval · 2024-12-16FDA Approved: NITROGLYCERIN — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals, Inc.'s generic nitroglycerin product under an Original Application (ANDA216452). This approval provides a …
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries [Phase 2, Phase 3]
This Stanford-initiated clinical trial is evaluating a targeted medical therapy for angina and nonobstructive coronary arteries in Phase 2/3…
-
FDA label_change · 2024-11-13FDA Approved: METOPROLOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Metoprolol Tartrate from Fresenius Kabi USA, LLC, indicating approved changes to labeling or for…
-
FDA approval · 2024-11-12FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for metoprolol tartrate (metoprolol) from Baxter Healthcare Corporation. This document indicates the…
-
FDA approval · 2024-11-08FDA Approved: IVABRADINE — Original Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals Limited's original application for a generic IVABRADINE product.
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease
A prospective registry study (COMPLEX Registry) enrolling patients with complex and calcified coronary artery disease. The goal is to descri…
-
FDA approval · 2024-10-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic diltiazem hydrochloride under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Impact of Body Weight on Outcomes of Patients Undergoing Coronary Artery Bypass Grafting
A completed clinical trial update from Medical University of Silesia evaluating the impact of body weight on outcomes after coronary artery …
-
FDA approval · 2024-09-25FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for metoprolol tartrate (metoprolol) under ANDA 202871, enabling a generic ve…
-
FDA approval · 2024-09-24FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s generic nicardipine hydrochloride (ANDA Original Application). Nicardipine hydrochloride is a calcium channel …
-
FDA approval · 2024-09-12FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for diltiazem hydrochloride by Mylan Pharmaceuticals Inc. under ANDA074910, indicating regulatory ap…
-
FDA approval · 2024-09-09FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride (Hospira, Inc.), confirming it as an approved generic drug under an ANDA…
-
FDA approval · 2024-09-06FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Chengdu Shuode Pharmaceutical Co., Ltd)
FDA approved nicardipine hydrochloride as an original-application product from Chengdu Shuode Pharmaceutical Co., Ltd.
-
EMA approval · 2024-09-06EMA Authorised: Ivabradine Accord (ivabradine hydrochloride) — Accord Healthcare S.L.U.
The EMA authorised Ivabradine Accord (ivabradine hydrochloride) from Accord Healthcare S.L.U. for the treatment of angina pectoris and heart…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)
Clinical trial update indicating the MACH15 study, which emulates moderate alcohol exposure and cardiovascular health, has completed.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Nurses' Health Study (Cardiovascular Component)
The Nurses' Health Study cardiovascular component is currently active but not recruiting, with conditions including cardiovascular diseases …
-
CLINICAL_TRIALS other · 2024-08-09Clinical Trial Update: Appropriateness of Angioplasty in Patients With Chronic Coronary Syndromes
An ongoing clinical trial sponsored by the University of Sao Paulo General Hospital is assessing whether angioplasty is appropriate for pati…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)
This clinical trial update indicates that the Tyrolean Aortic Stenosis Study-2 is currently recruiting to evaluate high-sensitivity Troponin…